chronic kidney disease

MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…

Aims Chronic kidney disease (CKD) is a major global health concern, often underdiagnosed in primary care settings. This…

Levin AS, Bilous RW, Coresh J. Chapter 1: definition and classification of CKD. Kidney Int Suppl. 2013;3(1):19–62. Google…

Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden…

One organ that does the most amount of work, without much fuss or chaos — it’s the kidneys.…

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B B, et al. IDF diabetes atlas:…

An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney…

Record numbers of men and women globally are now estimated to have reduced kidney function, a new study…

Chronic kidney disease (CKD) affects more than 700 million people worldwide and is caused by genetic and environmental…

When University of Texas at Arlington researcher Paul J. Fadel and his colleagues launched a study on vascular health in…

New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…

New evidence shows that restoring normal glucose regulation can shield against diabetes even without weight loss, reshaping prevention…

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease